BACKGROUND: Studies evaluating associations between body mass index (BMI) and optical coherence tomography (OCT) measures in multiple sclerosis (MS) are lacking. OBJECTIVE: To assess whether elevated BMI is associated with accelerated retinal atrophy. METHODS: In this observational study, 513 MS patients were followed with serial spectral-domain OCT for a median of 4.4 years. Participants were categorized as normal weight (BMI: 18.5-24.9 kg/m2), overweight (BMI: 25-29.9 kg/m2), and obese (BMI: ⩾30 kg/m2). Participants with diabetes mellitus or uncontrolled hypertension and eyes with optic neuritis (ON) ⩽6 months prior to baseline OCT or during follow-up were excluded. Statistical analyses were performed with mixed-effects linear regression. RESULTS: Obese patients (n = 146) exhibited accelerated rates of ganglion cell + inner plexiform layer (GCIPL) atrophy relative to normal weight patients (n = 214; -0.57%/year (95% confidence interval (CI): -0.65% to -0.48%) versus -0.42%/year (95% CI: -0.49% to -0.35%); p = 0.012). GCIPL atrophy rate did not differ between overweight (n = 153) and normal weight patients (-0.47%/year vs -0.42%/year; p = 0.41). Each 1 kg/m2 higher BMI was associated with accelerated GCIPL (-0.011%/year; 95% CI: -0.019% to -0.004%; p = 0.003) atrophy. Multivariable analyses accounting for age, sex, race, MS subtype, and ON history did not alter the above findings. CONCLUSIONS: Elevated BMI, in the absence of overt metabolic comorbidities, may be associated with accelerated GCIPL atrophy. Obesity, a modifiable risk factor, may be associated with accelerated neurodegeneration in MS.
BACKGROUND: Studies evaluating associations between body mass index (BMI) and optical coherence tomography (OCT) measures in multiple sclerosis (MS) are lacking. OBJECTIVE: To assess whether elevated BMI is associated with accelerated retinal atrophy. METHODS: In this observational study, 513 MSpatients were followed with serial spectral-domain OCT for a median of 4.4 years. Participants were categorized as normal weight (BMI: 18.5-24.9 kg/m2), overweight (BMI: 25-29.9 kg/m2), and obese (BMI: ⩾30 kg/m2). Participants with diabetes mellitus or uncontrolled hypertension and eyes with optic neuritis (ON) ⩽6 months prior to baseline OCT or during follow-up were excluded. Statistical analyses were performed with mixed-effects linear regression. RESULTS:Obesepatients (n = 146) exhibited accelerated rates of ganglion cell + inner plexiform layer (GCIPL) atrophy relative to normal weight patients (n = 214; -0.57%/year (95% confidence interval (CI): -0.65% to -0.48%) versus -0.42%/year (95% CI: -0.49% to -0.35%); p = 0.012). GCIPL atrophy rate did not differ between overweight (n = 153) and normal weight patients (-0.47%/year vs -0.42%/year; p = 0.41). Each 1 kg/m2 higher BMI was associated with accelerated GCIPL (-0.011%/year; 95% CI: -0.019% to -0.004%; p = 0.003) atrophy. Multivariable analyses accounting for age, sex, race, MS subtype, and ON history did not alter the above findings. CONCLUSIONS: Elevated BMI, in the absence of overt metabolic comorbidities, may be associated with accelerated GCIPL atrophy. Obesity, a modifiable risk factor, may be associated with accelerated neurodegeneration in MS.
Entities:
Keywords:
Multiple sclerosis; body mass index; optical coherence tomography; retina
Authors: Stephanie B Syc; Shiv Saidha; Scott D Newsome; John N Ratchford; Michael Levy; E'tona Ford; Ciprian M Crainiceanu; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Elliot M Frohman; Peter A Calabresi Journal: Brain Date: 2011-10-17 Impact factor: 13.501
Authors: John Gunstad; Robert H Paul; Ronald A Cohen; David F Tate; Mary Beth Spitznagel; Stuart Grieve; Evian Gordon Journal: Int J Neurosci Date: 2008-11 Impact factor: 2.292
Authors: B Dogan; M Kazim Erol; U Dogan; M Habibi; N Bulbuller; D Turgut Coban; M Bulut Journal: Eur Rev Med Pharmacol Sci Date: 2016-03 Impact factor: 3.507
Authors: S Schippling; L J Balk; F Costello; P Albrecht; L Balcer; P A Calabresi; J L Frederiksen; E Frohman; A J Green; A Klistorner; O Outteryck; F Paul; G T Plant; G Traber; P Vermersch; P Villoslada; S Wolf; A Petzold Journal: Mult Scler Date: 2014-06-16 Impact factor: 6.312
Authors: Prejaas Tewarie; Lisanne Balk; Fiona Costello; Ari Green; Roland Martin; Sven Schippling; Axel Petzold Journal: PLoS One Date: 2012-04-19 Impact factor: 3.240
Authors: Pavan Bhargava; Andrew Lang; Omar Al-Louzi; Aaron Carass; Jerry Prince; Peter A Calabresi; Shiv Saidha Journal: Mult Scler Int Date: 2015-05-18
Authors: Claudia Helena Marck; Sandra Leanne Neate; Keryn Louise Taylor; Tracey Joy Weiland; George Alexander Jelinek Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240
Authors: Marcus W Koch; Jop Mostert; Pavle Repovic; James D Bowen; Eva Strijbis; Bernard Uitdehaag; Gary Cutter Journal: J Neurol Date: 2021-08-15 Impact factor: 4.849
Authors: Eleni S Vasileiou; Angeliki G Filippatou; Daniela Pimentel Maldonado; Grigorios Kalaitzidis; Henrik Ehrhardt; Jeffrey Lambe; Shiv Saidha; Elias S Sotirchos; Ellen M Mowry; Peter A Calabresi; Kathryn C Fitzgerald Journal: Brain Date: 2021-12-31 Impact factor: 13.501
Authors: Jeffrey Lambe; Hunter Risher; Angeliki G Filippatou; Olwen C Murphy; Elias S Sotirchos; Henrik Ehrhardt; Esther Ogbuokiri; Nicole Pellegrini; Brandon Toliver; Nicholas J Luciano; Simidele Davis; Nicholas Fioravante; Ohemaa Kwakyi; Jerry L Prince; Peter A Calabresi; Kathryn C Fitzgerald; Shiv Saidha Journal: Neurology Date: 2021-04-07 Impact factor: 9.910
Authors: Jeffrey Lambe; Kathryn C Fitzgerald; Olwen C Murphy; Angeliki G Filippatou; Elias S Sotirchos; Grigorios Kalaitzidis; Elena Vasileiou; Nicole Pellegrini; Esther Ogbuokiri; Brandon Toliver; Nicholas J Luciano; Simidele Davis; Nicholas Fioravante; Ohemaa Kwakyi; Hunter Risher; Ciprian M Crainiceanu; Jerry L Prince; Scott D Newsome; Ellen M Mowry; Shiv Saidha; Peter A Calabresi Journal: Neurology Date: 2021-03-02 Impact factor: 9.910
Authors: Rituparna Goswami; Abudu I Bello; Joe Bean; Kara M Costanzo; Bwaar Omer; Dayanne Cornelio-Parra; Revan Odah; Amit Ahluwalia; Shefaa K Allan; Nghi Nguyen; Taylor Shores; N Ahmad Aziz; Ryan D Mohan Journal: Front Neurosci Date: 2022-03-24 Impact factor: 4.677
Authors: Valery Fuh-Ngwa; Yuan Zhou; Jac C Charlesworth; Anne-Louise Ponsonby; Steve Simpson-Yap; Jeannette Lechner-Scott; Bruce V Taylor Journal: Brain Commun Date: 2021-12-04